LYMErix (SmithKline Beecham)
LYMErix (SmithKline Beecham) Brand names, LYMErix (SmithKline Beecham) Analogs
LYMErix (SmithKline Beecham) Brand Names Mixture
- No information avaliable
LYMErix (SmithKline Beecham) Chemical_Formula
C1198H2012N322O422S2
LYMErix (SmithKline Beecham) RX_link
No information avaliable
LYMErix (SmithKline Beecham) fda sheet
LYMErix (SmithKline Beecham) msds (material safety sheet)
LYMErix (SmithKline Beecham) Synthesis Reference
No information avaliable
LYMErix (SmithKline Beecham) Molecular Weight
27743.1
LYMErix (SmithKline Beecham) Melting Point
No information avaliable
LYMErix (SmithKline Beecham) H2O Solubility
No information avaliable
LYMErix (SmithKline Beecham) State
Liquid
LYMErix (SmithKline Beecham) LogP
-0.652
LYMErix (SmithKline Beecham) Dosage Forms
Suspension (Injection)
LYMErix (SmithKline Beecham) Indication
For prophylactic treatment of Lyme Disease
LYMErix (SmithKline Beecham) Pharmacology
OspA lipoprotein is a single polypeptide chain of 270 amino acids. It is a vaccination used to prevent Lyme Disease.
LYMErix (SmithKline Beecham) Absorption
No information avaliable
LYMErix (SmithKline Beecham) side effects and Toxicity
No information avaliable
LYMErix (SmithKline Beecham) Patient Information
No information avaliable
LYMErix (SmithKline Beecham) Organisms Affected
Humans and other mammals
